Age-related alteration of pancreatic β-cell function: Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance

Diabetes Care

Volumn 19, Issue 1, 1996, Pages 8-11

  Shimizu, M ^a   Kawazu, S ^a   Tomono, S ^a   Ohno, T ^a   Utsugi, T ^a   Kato, N ^a   Ishii, C ^a   Ito, Y ^a   Murata, K ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; PROINSULIN;

AGED; AGING; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL;

EID: 0030045106     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.1.8     Document Type: Article

References (16)

1. Harris MI, Hidden WC, Knowler WC: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes 36:523-534, 1987
2. Leaky JL, Bonner-Weir S, Weir GC: Betacell dysfunction induced by chronic hyperglycemia. current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442-455, 1992
3. Taylor SI, Accili D, Imai Y: Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 43: 735-740, 1994
4. Kosaka K, Hagura R, Kuzuya T: Insulin responses in equivocal and definite diabetics, with special reference to subjects who had mild glucose intolerance but later developed diabetes. Diabetes 27: 944-952, 1977
5. Porte DJ, Kahn SE: Hyperproinsulinemia and amyloid in NIDDM. clues to etiology of islet beta-cell dysfunction? Diabetes 38. 1333-1336, 1989
6. Williams DRR, Borne C, Clark PMS: Raised proinsulin concentration as early indicator of β-cell dysfunction. Br Med J 303:95-96, 1991
7. World Health Organization. WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech Rep. Ser., no. 646)
8. Hunter WM, Greenwood JC: Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194: 495-496, 1962
9. Temple RC, Carrington CA, Luzio SD, Owens DR: Insulin deficiency in non-insulin-dependent diabetes Lancet 1:293-295, 1989
10. Saad MF, Kahn SE, Nelson RG: Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus J Clin Endocrinol Metab 70. 1247-1253, 1990
11. Yudkin JS: Circulating proinsulin-like molecules. J Diabetes Complications 7:113-123, 1993
12. Rhodes CJ, Alarc NC. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43: 511-517, 1994
13. Polonsky KS, Gumbiner B, Ostrega D, Gnver HT, Henry RR: Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes 43:871-877, 1994
14. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechitel G, Fink RI: Effects of aging on insulin secretion. Diabetes 38: 1549-1556, 1989
15. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN: Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 10:313-320, 1993
16. Raymond IF, Orville GK, Jennifer G, Lerrold MO: Mechanisms of insulin resistance in aging. J Clin Invest 71:1523-1535, 1983